| Health / Medical Topics |
Masitinib Mesylate
The orally bioavailable mesylate salt of masatinib, a multi-targeted protein tyrosine kinase inhibitor with potential antineoplastic activity. Masitinib selectively binds to and inhibits both the wild-type and mutated forms of the stem cell factor receptor (c-Kit; SCFR); platelet-derived growth factor receptor (PDGFR); fibroblast growth factor receptor 3 (FGFR3); and, to a lesser extent, focal adhesion kinase (FAK). As a consequence, tumor cell proliferation may be inhibited in cancer cell types that overexpress these receptor tyrosine kinases (RTKs). (NCI Thesaurus)
YOU MAY ALSO LIKE
Associated with men; befitting or characteristic of a man.
A proprietary scoring engine from Matrix Science that can match tandem mass spectra with peptide sequences.
A staging system for thymoma based on the anatomic extent of disease at the time of surgery.
The tumor shows lymphogenous or hematogenous metastasis to distant sites.
The tumor shows metastasis throughout the pleural and/or pericardial spaces.
The tumor shows invasion into the neighboring tissues and organs of the lower neck or upper chest.
